Bing Mei
CIK 1527293 · Chief Financial Officer · last filed 2018-11-15
Bing Mei is a Chief Financial Officer who has filed 6 SEC Form 4 insider transactions across 2 companies since 2012. The most recent filing, for KNDI, was dated Nov 15, 2018. Current disclosed insider exposure totals $14.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$14.0K
2
6
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KNDI | Chief Financial Officer | 20,000 | $0.70 | $14.0K | $0 | 4 | 2018-11-15 |
| SKYSTAR BIO-PHARMACEUTICAL CO (SKBI) Delisted | Chief Financial Officer | 26,000 | — | — | $0 | 2 | 2014-03-12 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-11-15 | KNDI | Grant (A) | +5,000 | $0 | EDGAR |
| 2018-06-29 | KNDI | Grant (A) | +2,500 | $0 | EDGAR |
| 2018-03-13 | KNDI | Grant (A) | +2,500 | $0 | EDGAR |
| 2017-03-10 | KNDI | Grant (A) | +2,500 | $0 | EDGAR |
| 2014-03-12 | SKYSTAR BIO-PHARMACEUTICAL CO (SKBI) Delisted | Grant (A) | +8,000 | $0 | EDGAR |
| 2012-05-08 | SKYSTAR BIO-PHARMACEUTICAL CO (SKBI) Delisted | Grant (A) | +18,000 | $46.4K | EDGAR |